News Feed

Latest updates

Shareholder-Exclusive Benefit! Shoucheng Holdings Launches Exclusive Entry Slots for Shareholders in the “2026 Beijing Yizhuang Half Marathon” – Robot Marathon Becomes a New Carrier for Shareholder Benefits

HONG KONG, March 9, 2026 - (ACN Newswire via SeaPRwire.com) – Recently, Shoucheng Holdings(697.HK) announced that it will provide direct entry slots for its shareholders to participate in the “2026 Beijing Yizhuang Half Marathon & Humanoid Robot Half Marathon,” drawing attention from the market. As one of the rare events globally that combines humanoid robots with a half marathon, the event is not only a sports race but also an important platform to showcase embodied intelligence technologies and the development of the robotics industry.It is worth noting that Shoucheng Holdings has opened the race entry quota as an exclusive shareholder benefit. Eligible shareholders may apply for direct registration without going through the official lottery process. This initiative is widely regarded as an innovative practice in investor relations management and reflects the company’s philosophy of opening its robotics industry ecosystem to shareholders.Industry observers believe this type of shareholder benefit carries symbolic significance. Traditionally, shareholder benefits of listed companies are mostly limited to dividends, gifts, or shareholder events. In contrast, Shoucheng Holdings integrates industrial resources with investor engagement, allowing shareholders to gain a more intuitive understanding of the robotics ecosystem the company is building through direct participation. In doing so, the company strengthens investor interaction while enhancing shareholders’ sense of participation and identification with the industry’s development.During the event, portfolio companies invested in by Shoucheng Holdings will appear at multiple points along the racecourse, forming a “mobile industrial exhibition.” While running, shareholders can:1. Naturally meet representatives of robotics companies at supply stations and rest areas, creating a relaxed atmosphere for open and candid exchanges.2. Discuss technical topics such as “the grasping logic of dexterous robotic hands under complex road conditions” and “how VLA models optimize robot motion control.”3. Build a concrete understanding of Shoucheng Holdings’ investment portfolio and gain insight into the logic behind its industrial and strategy.Registration DetailsThe “2026 Beijing Yizhuang Half Marathon & Humanoid Robot Half Marathon” is a landmark event that integrates sports competition with cutting-edge technology. As a co-organizer, Shoucheng Holdings (0697.HK) has established exclusive direct-entry slots for shareholders. Through a dedicated application channel, qualified shareholders can register without participating in the official lottery.Event InformationEvent Name: 2026 Beijing Yizhuang Half Marathon & Humanoid Robot Half MarathonRace Date: April 19, 2026 (Sunday)Location: Beijing Economic-Technological Development Area (Yizhuang)Organizing Participants: Jointly organized with Shoucheng Holdings (0697.HK)Application AccessPlease click the link below or scan the QR code to enter the exclusive application channel, fill in the required information, and upload proof of shareholding.Eligibility and Key TimelineTo safeguard shareholder rights and interests, applications must meet the following conditions and strictly follow the timeline arrangements.Application Requirements:1. Must be a shareholder of Shoucheng Holdings (0697.HK).2. Must provide clear proof of shareholding (e.g., a screenshot of holdings from a trading platform showing the shareholder’s name and shareholding information).3. Slots are limited and will be allocated based on the order in which applications are submitted.Runner Qualification Requirements (Unified Regulations by the Organizing Committee):1. Performance Requirement: Between March 1, 2024 and the registration deadline, runners must have completed at least two races of 10 km or longer.2. Proof Materials: Valid proof of race completion must be uploaded during registration (official certificates, screenshots from running apps, etc.).3. Qualification Review: All participants must pass a background check conducted by the public security authorities to ensure event safety and order.Key TimelineDateMilestoneDescriptionMarch 10, 2026Application DeadlineComplete the online application and submit valid proof of shareholding. Late submissions will not be accepted.March 16, 2026Invitation Code Registration DeadlineApproved shareholders must complete official registration with the organizing committee before this date; otherwise the slot will be considered forfeited.April 19, 2026Race DayCompete on the Yizhuang racecourse in Beijing alongside humanoid robots.In recent years, Shoucheng Holdings has continued to increase its investment in the robotics industry. Through industrial funds and platform investments, the company has invested in multiple embodied intelligence enterprises, gradually building an industrial system covering complete robots, core technologies, and application scenarios. This event is also regarded as an important window to showcase the company’s robotics ecosystem. By integrating race participation with industry exhibitions, the company enables shareholders to experience how robotics technologies move from laboratories into real-world applications.All shareholders are welcome to actively register and participate, and jointly witness the important moment when the robotics industry moves from the laboratory into the real world. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

8 3 月, 2026

Xunce (3317.HK) Released Profit Alert: Revenue Doubles, Surpasses Expectations by a Wide Margin, China’s Palantir Rises!

HONG KONG, March 6, 2026 - (ACN Newswire via SeaPRwire.com) – Hong Kong Shenzhen Xunce Technology Co., Ltd. (“Xunce Technology” or the “Company”, stock code: 3317.HK) announced a profit alert announcement. Against the backdrop where most industry peers are still in the investment stage and burning capital continuously, the Company has withstood the test of market cycles and delivered a remarkable performance that substantially outperformed the market consensus, demonstrating strong growth resilience and improving profitability.According to the Company’s announcement, during the reporting period, the Company recorded revenue of RMB 1,283 million, representing a substantial year-on-year increase of 102.95%, with a qualitative leap in profitability. Excluding non-recurring gains or losses, the Company’s adjusted net loss for 2025 amounted to RMB 55 million, representing a significant narrowing as compared with 2024, reflecting continuous improvement in operating quality.In terms of business performance, both the revenue scale and the extent of loss reduction significantly exceeded market analysts’ expectations (Wind Consensus Estimate: revenue RMB 987 million, net profit – RMB 134 million). Particularly noteworthy is that the Company’s revenue for the second half of 2025 surged by 448% compared with the first half, demonstrating a strong quarterly explosive growth trend. The Company’s performance growth momentum has been fully released, with its development drivers continuously strengthened.A Successful Business Model and Forward-Looking Strategy Driving Explosive Performance GrowthClearly, this is inseparable from the strong support of Xunce Technology’s forward-looking strategic layout and successful business model. At the business model level, Xunce Technology has deeply deployed its core technologies and solutions on clients’ self-managed cloud or local systems. Its services cover the top 10 asset management companies in China by asset management scale, and the Company has successfully expanded its solutions to diversified industries beyond asset management, establishing a solid industry leadership position.It is precisely this solid and highly-engaged customer base that has enabled the Company to seize the opportunities of the new wave of technological innovation. In 2025, global AI large models entered a new stage of large-scale deployment, with AI infrastructure and industry solutions rapidly penetrating diverse application scenarios. Enterprises’ demand for real-time, high-quality, and structured data has grown exponentially. The Company has accurately captured these industry opportunities,  continued to increase investment in technology R&D and product iteration, and comprehensively upgraded its real-time data platform and AI Agent capabilities. These efforts efficiently meet the data processing, governance, and application requirements of the large-model era, making a major contribution to the Company’s strong performance growth.Another key driver behind the Company’s explosive performance growth comes from business expansion in emerging sectors. In 2025, the Company continued to make breakthroughs in cutting-edge emerging fields such as commercial aerospace, robotics, and intelligent manufacturing, where the market demand for related data solutions has surged dramatically.As enterprise-level AI applications have officially entered a paid adoption boom cycle, the Company has continuously deepened and upgraded its cooperative relationships with core clients. Clients’ willingness to pay for data infrastructure and intelligent analysis services has increased significantly, driving a leap in ARPU. This has further expanded the Company’s performance growth boundaries and unlocked greater room for revenue expansion.Looking ahead, as the Company progressively upgrades its business model to multiple models, including by-token pricing for API invocations, by-token charges for model training, and performance-based payment and revenue-sharing mechanisms, its profit structure will continue to be optimized. The predictability and sustainability of its revenue will be significantly enhanced, enabling the Company to build a more solid growth trajectory and broader profit potential, thereby driving high-quality and sustainable long-term growth in its operating performance.Operating Efficiency Surges, High-Growth Attributes Clearly EstablishedFrom the perspective of key operating indicators, Xunce Technology, with its AI Data Agent at the core, has continuously strengthened its real-time data processing capabilities and built a full-chain technology system with scenario-based applications, achieving dual breakthroughs in operating efficiency and commercial value:The Company’s revenue per employee has reached RMB 2.9 million, approximately double that of traditional software enterprises, reflecting a significant improvement in workforce productivity and setting a new benchmark for industry efficiency. ARPU has surged to RMB 5.56 million, representing a year-on-year doubling from RMB 2.72 million in 2024. This marks a major breakthrough and demonstrates the continued strengthening of the Company’s product competitiveness and growing recognition of its value among customers.In terms of revenue performance, the Company recorded revenue of RMB 1.283 billion in 2025, surpassing the RMB 1 billion scale threshold and marking its entry into a new stage of high-quality development. This milestone reflects a notable strengthening of both scale effects and commercialization capabilities. The Company’s growth rate significantly outpaced the industry average, demonstrating robust growth momentum.Overall, leveraging its leading business model, continuous product innovation, and efficient operating system, the Company has been advancing steadily along the path of high-quality development. Its profitability, growth potential, and industry competitiveness have become increasingly prominent, clearly establishing its high-growth profile.Benchmarking Against Global Data Giant Palantir, Unlocking Long-Term Growth PotentialIn fact, the comprehensive competitiveness of Xunce Technology extends far beyond the above achievements. At the strategic level, the Company has long established a clear development blueprint with immense long-term potential: benchmarking against the world-leading data giant Palantir, it has built full-chain capabilities spanning data acquisition, governance, analysis, and large-model scenario applications, with a high degree of alignment in technical architecture, business model, and growth path. As the Company continues to consolidate its technological barriers and its performance enters a phase of high-speed explosive growth, the market-recognized “China’s version of Palantir” has officially emerged, with its long-term growth potential fully unlocked.The explosive growth delivered in this round of results has further enabled the market to clearly recognize the Company’s scarce intrinsic strengths and the true depth of its value. As a highly scarce investment target in the AI data infrastructure sector of the Hong Kong stock market, the Company has built hard-to-replicate competitive barriers across multiple dimensions, including its product matrix, core technologies, business model and high-quality customer resources. Positioned as a premium core asset in the data track of the large-model era, it is well poised to become the top AI data stock in the Hong Kong stock market.From an industry perspective, competition in the large-model track has formally entered the second half, with the focus shifting away from the models themselves toward AI data infrastructure. A strong industry consensus has emerged that the upper limit of an enterprise’s AI capability is ultimately determined by the quality of its data. Those that possess real-time, structured and scenario-based data processing and application capabilities will be able to establish irreplaceable core competitiveness in the AI era. These structural industry tailwinds are expected to provide solid and sustainable growth momentum for Xunce Technology’s long-term high-quality development.Overall, against the backdrop of widespread pressure across the industry, where investment often outweighs returns, Xunce Technology has delivered results that significantly exceed market expectations, supported by four core strengths: technological leadership, robust product capabilities, diversified expansion and improved operational efficiency. This performance has fundamentally reshaped the capital market’s perception of the Company’s value. Looking ahead, the Company will continue to deepen its focus on the AI data infrastructure track, leveraging technological innovation and the expansion of application scenarios to continuously unlock its growth potential, with substantial long-term development potential. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

6 3 月, 2026

Hong Kong Completes First Green Methanol Bunkering, Driving Green Transformation of Its International Shipping Hub

HONG KONG, March 6, 2026 - (ACN Newswire via SeaPRwire.com) – 5 March 2026, the world’s first methanol dual-fuel roll-on/roll-off vessel, CM HONG KONG, successfully completed its first green methanol bunkering operation in Hong Kong. This also marks China's first green methanol bunkering operation conducted at anchor.This milestone signifies a major breakthrough in the Hong Kong Special Administrative Region Government’s deepened collaboration with enterprises including China Merchants Group (CMG), China Petroleum & Chemical Corporation (Sinopec Group), and China International Marine Containers Group (CIMC). The achievement responds proactively to the “Dual Carbon” goals and advances implementation of Hong Kong’s Action Blueprint for Green Marine Fuel Bunkering, marking a solid step forward in Hong Kong’s development into an international green marine fuel bunkering centre.The bunkering ceremony, themed “RIDING THE TIDE, GREENING THE FUTURE”, was jointly hosted by China Merchants Energy Shipping (CMES), Sinopec (Hong Kong), and CIMC Enric at the Legislative Council Complex. Officiating guests included the Secretary for Transport and Logistics of the Government of the Hong Kong Special Administrative Region, the Hon Mable CHAN, JP; the Under Secretary for Environment and Ecology, Diane WONG Shuk-han, JP; the Director of Marine, WONG Sai-fat, together with Members of the Legislative Council, the Hon Gary CHAN Hak-kan, SBS, JP; the Hon Judy CHAN Kapui, MH, JP; the Hon Erik YIM Kong, JP; the Hon Aaron BOK Kwok-ming; Dr the Hon Webster NG Kam-wah, JP; Capt the Hon Lothair LAM Ming-fung; and the Hon Tommy CHUNG Ki-fung. Representatives from CMG, Sinopec, and CIMC, along with more than 100 distinguished guests from the shipping, energy, equipment manufacturing, and financial sectors, witnessed the significant moment.During the ceremony, officiating guests jointly launched the bunkering operation. A live screen broadcast the “first injection” of green methanol into CM HONG KONG, while simultaneously displaying the internationally certified green attribute certificate.The vessel completed bunkering via a ship-to-ship (STS) transfer, receiving approximately 500 tonnes of green methanol. According to calculations, this volume is expected to reduce greenhouse gas emissions by approximately 85% compared with conventional marine fuels.The green methanol was produced and supplied by CIMC Enric and has obtained ISCC EU certification. The bunkering operation was carried out through Sinopec (Hong Kong)’s professional bunkering service system, and the fuel was ultimately applied by CMES as the shipowner. The operation fully demonstrated a closed-loop green methanol value chain encompassing “production–storage–shipping–bunkering–application”.Pursuant to the Strategic Cooperation Agreement on Jointly Building the Hong Kong Green Methanol Bunkering Centre signed in November 2025, the three parties leveraged their respective core strengths in ocean shipping, oil and gas and green fuel storage-transport-sales, and energy equipment manufacturing. Technical validation, solution optimisation, and emergency preparedness were completed in advance to ensure smooth implementation.To ensure safe and efficient operations, relevant HKSAR Government departments worked in close coordination with participating enterprises. The Transport and Logistics Bureau, Marine Department, Customs and Excise Department, and Immigration Department provided end-to-end support in policy guidance, streamlined approvals, and safety oversight in accordance with the Action Plan on Green Maritime Fuel Bunkering.This inaugural bunkering is not merely a technical demonstration, but a pivotal practice in establishing Hong Kong’s green marine fuel bunkering ecosystem. It verifies both the technical feasibility and commercial operability of green methanol bunkering in Hong Kong, and showcases a “Hong Kong’s Approach” characterised by government-enterprise collaboration, port-shipping synergy, and full industry-chain coordination. This initiative helps attract more green vessels to call at Hong Kong and encourages Hong Kong-registered vessels to increase their usage of green marine fuels, striving to achieve the target of 7% by 2030.The three organizations that collaborated to complete this bunkering operation stated that they would continue to further deepen cooperation, promote the industrialisation, scaling, and regularisation of green methanol supply in Hong Kong, and accelerate the establishment of a comprehensive ecosystem covering production, storage, shipping, bunkering, trading, and financial services. These efforts will support Hong Kong in building a leading green maritime fuel bunkering and trading centre in the Asia-Pacific region, contributing to the national “Dual Carbon” goals, Hong Kong’s carbon neutrality, and the global low-carbon transformation of the shipping industry.PhotosCaption Photo 1Bunkering process of CM HONG KONG Photo 2Bunkering process of CM HONG KONGPhoto 3 Bunkering of the world's first methanol dual-fuel roll-on/roll-off vessel CM HONG KONG in Hong KongPhoto 4Group Photo of All Guests at the Hong Kong’s First Green Methanol Bunkering CeremonyPhoto 5Group Photo of the Kickoff Ceremony at the Hong Kong’s First Green Methanol Bunkering Ceremony Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

6 3 月, 2026

Hong Kong Tech Innovators Drive Success at Mobile World Congress and 4YFN Barcelona 2026

HONG KONG, March 6, 2026 - (ACN Newswire via SeaPRwire.com) – Hong Kong Trade Development Council (HKTDC), in collaboration with Hong Kong Science and Technology Parks Corporation (HKSTP), led a delegation of 20 local innovation and technology (I&T) companies and institutions to Barcelona, Spain, concluding a highly successful participation at the world’s premier connectivity event—Mobile World Congress (MWC), and debuted at the startup-centric stage—4 Years From Now (4YFN) 2026. This participation has enabled local tech firms to access markets overseas, showcasing their strengths in research and development (R&D), and demonstrating the city’s role as a leading international I&T hub.The delegation effectively spotlighted Hong Kong’s cutting-edge innovative solutions in Connectivity, Devices and Systems, Digital Transformation, and support from Ecosystem Partners, successfully engaged global industry leaders and investors to generate business collaboration, technology co-development and investment opportunities.Iris Wong, Director, Merchandise Trade and Innovation / Director, External Relations, HKTDC, said, “Hong Kong is committed to developing into an international I&T centre, actively promoting cross-industry integration and driving high-quality development of the industries through technological innovation. We possess a robust mobile communications infrastructure, and the industry is highly competitive in research and development as well as technology related to 5G/6G applications and AI integration. This year, the Hong Kong Tech Pavilion adopts a dual-pavilion layout to showcase the city's I&T capabilities on two international platforms – MWC and 4YFN – helping the industry expand into European and broader global business opportunities.”Derek Chim, Head of Startup Ecosystem and Development, HKSTP said, “MWC and 4YFN bring together the world’s most influential stakeholders across connectivity and innovation ecosystems. Our dual-zone presence gave our innovators the global stage to validate solutions, gain visibility and drive business traction. HKSTP will continue to strengthen the I&T ecosystem and bring Hong Kong's research excellence to Europe and beyond.”A series of dialogues and exchanges—spanning networking reception and themed talks to pitching sessions—were held at the Pavilions and attracted an enthusiastic response. The events highlighted the dynamism of Hong Kong’s I&T ecosystem to European audiences, while enabling participants to more deeply understand the city’s unique advantages as a “super-connector” and “super value-adder”. This positions the city as a strategic springboard for international companies entering Asian markets, while enabling local and Chinese Mainland firms to leverage this edge to expand globally.Following his visit to the Hong Kong Tech Pavilion, Alejandro Gallego, International Business Director of AMEC, said: “The Hong Kong Pavilions are highly inspirational, and the exhibiting companies we visited showcased exceptionally innovative technological solutions. We have started conversations with Hong Kong companies to explore concrete opportunities for collaboration.”Jacobo Pérez-Soba, Manager of the Internationalisation Department, Madrid Chamber of Commerce & Industry, said: “The solutions and services provided by Hong Kong companies are highly forward-looking and demonstrate outstanding technological advancement. I also learned about upcoming tech events in Hong Kong, which are expected to be of significant interest to Spanish companies and startups.”As 2026 marks the opening year of China’s 15th Five-Year Plan, with technological innovation as one of the national priorities, HKTDC shall continue to join hands with HKSTP to support local tech firms in "going global" through jointly organising the Hong Kong Tech Pavilion, accelerating Hong Kong’s I&T by building a vibrant, internationally competitive ecosystem and fostering the development of new quality productive forces.Photo download: https://bit.ly/3Nm5qHlHong Kong Tech Pavilion debuted a dual presence at MWC and 4YFN 2026, featuring 20 Hong Kong I&T companies and institutions in Barcelona to showcase the city’s innovative technology solutions. Throughout the four-day event, the Hong Kong Tech Pavilion at MWC saw a constant stream of visitors, attracting a significant number of international telecom operators, corporate decision-makers, and investors. The Hong Kong Tech Pavilion debuted at the startup-centric 4YFN, served as a vibrant stage for Hong Kong’s up-and-coming innovation power. A series of dialogues and exchanges—spanning networking reception and themed talks to pitching sessions—were held at the MWC Pavilion and attracted an enthusiastic response. The seminar “Ready for Asia' Take the Fast Track Through Hong Kong” was held at the Pavilion to share strategies for international companies to enter Asian markets, speakers included (starts from the second left in Photo 6) Chris Lo, Regional Director, Europe, Central Asia & Israel of HKTDC; Paula Kant, Head, Investment Promotion of InvestHK; Jennifer Chan, Board Member of HKSTP; Prof Christopher Chao, Senior Vice President (Research and Innovation) of The Hong Kong Polytechnic University and Daniel Garcia, Founder of a Spain startup VirtuaBroker. Another seminar, the "Hong Kong Tech Disrupt" featured insights from Jennifer Chan, Board Member of HKSTP (first from left); Derek Chim, Head of Startup Ecosystem and Development of HKSTP (middle); alongside were representatives from park companies, including Kinson Chan, CEO of eSIX Limited (second from right) and Edward Mak, CEO & Founder of Vista InnoTech (second from left). The seminar drew attention from numerous professionals in the European technology sector.Full list of 20 tech entities showcasing at Hong Kong Tech Pavilion during MWC and 4YFN 2026:MWC 2026 – Booth 6E44 at Hall 61Entoptica LimitedDevices & Systems2eSIXConnectivity3Faraconix Technologies Co., Ltd.Connectivity4FreightAmigo Services LimitedDigital Transformation5Glassdio Scientific Company LimitedConnectivity6Harvest Elite International LimitedDigital Transformation7HongKong Umedia LimitedDevices & Systems8iASPEC Services LimitedDigital Transformation9InvestHKEcosystem Partners10Robocore Technology LimitedDevices & Systems11Shannon & Turing Technology LimitedConnectivity12The Hong Kong Polytechnic UniversityEcosystem Partners13Xeroptix TechnologyDevices & Systems4YFN 2026 – Booth 8.1B31 at Hall 8.114AIGM LimitedDigital Transformation15BWSea Technology (HK) Co., LimitedDigital Transformation16Cresento LimitedDevices & Systems17GoGoChart Technology LimitedDigital Transformation18HairCoSys LimitedDevices & Systems19KNQ Technology LimitedDigital Transformation20Vista Innotech LimitedDevices & SystemsAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in Chinese Mainland, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels.About Hong Kong Science and Technology Parks CorporationHong Kong Science and Technology Parks Corporation (HKSTP) was established in 2001 to create a thriving I&T ecosystem grooming 12 unicorns, more than 16,000 research professionals and over 2,400 technology companies from 24 countries and regions focused on developing healthtech, AI and robotics, fintech and smart city technologies, etc.Our growing innovation ecosystem offers comprehensive support to attract and nurture talent, accelerate and commercialise innovation for technology ventures, with the I&T journey built around our key locations of Hong Kong Science Park in Pak Shek Kok, InnoCentre in Kowloon Tong and three modern InnoParks in Tai Po, Tseung Kwan O and Yuen Long realising a vision of new industrialisation for Hong Kong, where sectors including advanced manufacturing, micro-electronics and biotechnology are being reimagined.Hong Kong Science Park Shenzhen Branch in Futian, Shenzhen plays positive roles in connecting the world and the mainland with our proximity, strengthening cross-border exchange to bring advantages in attracting global talent and allowing possibilities for the development of technology companies in seven key areas: Medtech, big data and AI, robotics, new materials, microelectronics, fintech and sustainability, with both dry and wet laboratories, co-working space, conference and exhibition facilities, and more.Through our R&D infrastructure, startup support and enterprise services, commercialisation and investment expertise, partnership networks and talent traction, HKSTP continues to contribute in establishing I&T as a pillar of growth for Hong Kong. More information about HKSTP is available at www.hkstp.org.Media Contact:Hong Kong Science and Technology Parks CorporationAngela Lau, +852 6535 7611, angela.lau@hkstp.orgHong Kong Trade Development CouncilWinnie Kan, +852 2584 4055, winnie.wy.kan@hktdc.org Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

6 3 月, 2026

Anime Tokyo Station: “That Time I Got Reincarnated as a Slime” Special Exhibition, February 21 to May 24, 2026

TOKYO, Mar 6, 2026 - (JCN Newswire via SeaPRwire.com) - Anime Tokyo Station is an anime exhibition site focused on Japanese anime content, which has developed a devout fan base around the world. From February 21 (Sat.) to May 24 (Sun.), 2026, it will be holding the “That Time I Got Reincarnated as a Slime” Special Exhibition. A preview was held for the press on February 20 (Fri.), the day before the exhibition opened.©Taiki Kawakami, Fuse, KODANSHA/ “Ten-Sura” ProjectThis special exhibition looks back on the story through the third season of the TV anime, highlighting iconic scenes and memorable lines. Visitors can enjoy exhibits unique to Anime Tokyo Station, including interactive digital content and a photo spot where they can take commemorative photos with Rimuru. With displays that unfold alongside character introductions and other features, even those who have not yet seen the anime can enjoy the exhibition as preparation for the film set for release in late February and the fourth season of the TV anime starting in April.Come to Anime Tokyo Station and experience the appeal of “That Time I Got Reincarnated as a Slime.”Exhibits©Taiki Kawakami, Fuse, KODANSHA/ “Ten-Sura” ProjectAbout the SeriesWhat is “That Time I Got Reincarnated as a Slime”?“That Time I Got Reincarnated as a Slime” is an isekai anime series following a protagonist who is reincarnated as a slime in another world, using the skills he acquires along with his wits and courage to gather allies. The first season of the TV anime aired on TOKYO MX and other channels from October 2018 to March 2019.In 2021, TV anime Season 2 Part 1 aired from January to March, followed by the spin-off comic adaptation “Slime Diaries: That Time I Got Reincarnated as a Slime” from April to June, and TV anime Season 2 Part 2 from July to September, making for nine consecutive months of broadcasts. Then, on November 25, 2022, “That Time I Got Reincarnated as a Slime: The Movie – Scarlet Bond” was released nationwide, becoming a major hit with over one million admissions and box office revenue of 1.4 billion yen in Japan.To commemorate the 10th anniversary of the web novel “That Time I Got Reincarnated as a Slime,” the Tensura 10th Project launched on February 20, 2023. As part of this project, the all-new three-episode animation “That Time I Got Reincarnated as a Slime: Visions of Coleus” began streaming on November 1, 2023. On December 16, 2023, the series’ first large-scale event, That Time I Got Reincarnated as a Slime: Tensura 10th Live, was held at Mori no Hall 21 in Matsudo. Furthermore, the third season of the TV anime aired from April to September 2024. Following the final episode of Season 3, production of a second theatrical film and Season 4 of the TV anime was announced. “That Time I Got Reincarnated as a Slime: The Movie – Tears of the Azure Sea” is set to release on February 27, 2026.The original manga “That Time I Got Reincarnated as a Slime” (serialized in Kodansha’s Monthly Shonen Sirius / Manga: Taiki Kawakami, Original story: Fuse, Character design: Mitz Vah) is a comic adaptation of the popular web novel of the same name by Fuse, which surpassed 1 billion page views on the user-generated novel publishing website “Shosetsuka ni Naro.” The combined worldwide circulation of the manga, novels, and spin-off works has exceeded 56 million copies (as of June 2025).* “Shosetsuka ni Naro” is a registered trademark of HinaProject Inc.Tensura Portal Site: ten-sura.comOfficial X: @ten_sura_anime / Official Instagram: tensura_official / Official TikTok: @ten_sura_animeEvent OverviewTitle:“That Time I Got Reincarnated as a Slime” Special ExhibitionDates:February 21, 2026 to May 24, 2026Name:Anime Tokyo Station (also known as "Anime Tokyo")Location:Floors B1 to 2F of Tokyu East 5 (2-25-5 Minami-Ikebukuro, Toshima-ku, Tokyo) * 4 minutes on foot from Ikebukuro StationHours:11:00 a.m. to 7:00 p.m. (last admission: 6:45 p.m. / Special exhibitions close: 6:30 p.m.)Closed:Mondays* If Monday falls on a holiday, the venue will be open on Monday and closed on the following dayNew Year's holiday periodMay be closed on other daysPlease check the venue website before coming.Admission fee:FreeWebsite:https://animetokyo.jp/en/SNS:X|https://x.com/animetokyo_info (@animetokyo_info)Instagram|https://www.instagram.com/animetokyostation/(@animetokyostation)YouTube|https://www.youtube.com/channel/UCSJOjGJE5Yiqw3PZ97AVdJwInquiries regarding this press releasePublic Relations Office of "Anime Tokyo Station" (Kyodo PR)Contact person: Miri YasudaE-mail: animetokyo-pr@kyodo-pr.co.jp Press release: https://www.acnnewswire.com/docs/files/20260306.pdf  Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

6 3 月, 2026

U.S. Polo Assn. Expands Collegiate Partnership Program to Record 70 Teams for 2026 Season

West Palm Beach, FL, Mar 5, 2026 - (ACN Newswire via SeaPRwire.com) - U.S. Polo Assn., the official sports brand of the United States Polo Association (USPA), proudly announces the continued expansion of its Collegiate Partnership Program (CPP) for the 2026 season and academic year. Now in its eighth consecutive year, the program reaches a historic milestone by supporting 70 collegiate teams across 31 universities nationwide, the largest number of teams ever participating in the program.U.S. Polo Assn.'s Collegiate Partnership Program featuring the California Polytechnic State University Women's and Men's Polo TeamsPhoto Credit: California Polytechnic State University Polo TeamsU.S. Polo Assn. will outfit hundreds of student-athletes from coast to coast, including small private and large public institutions, Ivy League Universities, and Historically Black Colleges and Universities (HBCUs). The CPP supports 35 women's and 35 men's teams, reinforcing U.S. Polo Assn.'s long-standing commitment to growing the sport at the collegiate level. This season welcomes two new schools, Babson University and Southern Methodist University, joining a distinguished group of institutions nationwide.This year, U.S. Polo Assn. will generously provide each partnered program with custom-performance team jerseys, white performance game pants, polo shirts, caps, equipment gear bags, and exclusive USPA Pro merchandise, along with a monetary donation. The program also continues its popular collegiate social media contest, where teams have the opportunity to win additional prizes through creative digital engagement and storytelling.Participating Schools Include:Babson UniversityMorehouse CollegeTrinity UniversityUniversity of North TexasBrown UniversityOklahoma State UniversityUniversity of California - DavisUniversity of Southern CaliforniaCalifornia Polytechnic State UniversityOregon State UniversityUniversity of ConnecticutUniversity of South Carolina - AikenColorado State UniversitySkidmore CollegeUniversity of IdahoUniversity of VirginiaCornell UniversitySouthern Methodist UniversityUniversity of KentuckyUniversity of Wisconsin - MadisonGeorgetown UniversityStanford UniversityUniversity of MarylandVirginia Tech UniversityMichigan State UniversityTexas A&M UniversityUniversity of MichiganYale UniversityMontana State UniversityTexas Tech UniversityUniversity of New Hampshire "U.S. Polo Assn. is proud to support a record number of collegiate polo teams and student-athletes through the Collegiate Partnership Program," said J. Michael Prince, President and CEO of USPA Global, the company that manages the multi-billion-dollar U.S. Polo Assn. brand. "This critical program strengthens the foundation of the sport by providing meaningful resources to collegiate polo programs across the country. Supporting 70 teams this season reflects both the growth of the program and our long-term commitment to supporting the next generation of players both on and off the polo field."Enrollment for U.S. Polo Assn.'s Collegiate Partnership Program is open to all colleges and universities with a USPA-sanctioned polo team and lasts for the academic year. Collegiate polo teams compete in the Fall and Spring, with the official season running through April 2026 and culminating in the National Intercollegiate Championship (NIC)."Our partnership with U.S. Polo Assn. for the last eight years continues to make a meaningful difference for collegiate programs nationwide," said Liz Brayboy, Chair of the USPA's Intercollegiate/Interscholastic Committee. "The support provided through the Collegiate Partnership Program helps teams build stronger programs, develop student-athletes, and showcase the spirit and sportsmanship that define collegiate polo."The two-time award-winning series Breakaway, created by Global Polo, the media subsidiary of USPA Global, will feature a new episode in its upcoming season. Titled "Breakaway: Polo in College," the episode will air later this year on ESPNU, offering national exposure to the excitement and impact of collegiate polo. Check your local listings for air times.About U.S. Polo Assn. and USPA GlobalU.S. Polo Assn. is the official sports brand of the United States Polo Association (USPA), the largest association of polo clubs and polo players in the United States, founded in 1890 and located in Wellington, Florida. With a multi-billion-dollar global footprint and worldwide distribution through more than 1,200 U.S. Polo Assn. retail stores as well as thousands of additional points of distribution, U.S. Polo Assn. offers apparel, accessories, and footwear for men, women, and children in more than 190 countries worldwide. The brand sponsors major polo events around the world, including the U.S. Open Polo Championship®, held annually at NPC in The Palm Beaches, the premier polo tournament in the United States. Historic deals with ESPN in the United States, TNT and Eurosport in Europe, and Star Sports in India now broadcast several of the premier polo championships in the world, sponsored by U.S. Polo Assn., making the thrilling sport accessible to millions of sports fans globally for the very first time.U.S. Polo Assn. has consistently been named one of the top global sports licensors in the world alongside the NFL, PGA Tour, and Formula 1, according to License Global. In addition, the sport-inspired brand is being recognized internationally with awards for global growth. Due to its tremendous success as a global brand, U.S. Polo Assn. has been featured in Forbes, Fortune, Modern Retail, and GQ as well as on Yahoo Finance and Bloomberg, among many other noteworthy media sources around the world. For more information, visit uspoloassnglobal.com and follow @uspoloassn.USPA Global is a subsidiary of the United States Polo Association (USPA) and manages the multi-billion-dollar sports brand, U.S. Polo Assn. USPA Global also manages the subsidiary, Global Polo, which is the worldwide leader in polo sport content. To learn more, visit globalpolo.com or Global Polo on YouTube.For Additional Information, Contact:Shannon Stilson - VP, Sports Marketing and MediaPhone +001.561.227.6994 - E-mail: sstilson@uspagl.comStacey Kovalsky - VP, Global PR and CommunicationsPhone +001.561.790.8036 - E-mail: skovalsky@uspagl.comSOURCE: U.S. Polo Assn. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

5 3 月, 2026

Lancaster Resources Announces Resignation of Penny White and the Addition of Rob Heaslop to the Board of Directors

Vancouver, British Columbia--(ACN Newswire via SeaPRwire.com - March 5, 2026) - Lancaster Resources Inc. (CSE: LCR) (OTC Pink: LANRF) (FSE: 6UF0) ("Lancaster" or the "Company") announces the director resignation of Penny White, effective March 3, 2026. The Board thanks Penny White for her valuable contributions during her tenure and wishes her continued success in her future endeavors.The Company is also pleased to announce the appointment of Mr. Rob Heaslop, as a director to the company's Board of Directors, effective immediately.Mr. Heaslop is a geologist with 20 years' of exploration and resource development experience in Africa, Australia, and the Pacific with specific expertise in project generation and early stage targeting for precious and base metal deposits. Mr. Heaslop holds a Bachelor of Science (Hons) from The University of Queensland majoring in earth science and geology, and during his career has worked for major, junior, and private exploration and mining companies. In 2016, Mr. Heaslop founded his privately owned project generation company, MRG Resources Pty Ltd, that has created significant value identifying exploration opportunities in Australia, including deals with major and mid-tier mining houses and private exploration companies. Mr. Heaslop is a member of the Australasian Institute of Mining and Metallurgy (MAusIMM), Australian Institute of Geoscientists (MAIG), and the Society of Economic Geologists (SEG)."We are thrilled to welcome Mr. Heaslop to the Board," said Andrew Watson, President & CEO of Lancaster Resources. "His technical expertise will be invaluable as Lancaster continues to develop our Lake Cargelligo gold project, Lac Iris polymetallic asset, and our other critical and precious mineral assets."Rob Heaslop commented, "I am focused on the opportunities ahead and committed to help navigate a successful exploration program for our projects and shareholders. I am truly excited to continue working with the team here."The new board appointment reflects Lancaster Resources' transition to a new corporate direction and commitment to strengthening its leadership and strategic capabilities to enhance shareholder value and propel the company's growth in the mining industry.Andrew Watson, P.Eng., President & CEO and a Director of the Company, is a Qualified Person as defined under National Instrument 43-101 – Standards of Disclosure for Mineral Projects. Mr. Watson has reviewed and approved the scientific and technical information contained in this news release. Mr. Watson is a Director and the President and CEO of Lancaster and is not independent of the Company.About Lancaster Resources Inc. Lancaster Resources Inc. is a Canadian exploration company advancing a diversified portfolio of gold and silver exploration projects in established mining jurisdictions. The Company holds a 100% interest in the Lake Cargelligo Gold Project in New South Wales, Australia, which is prospective for both gold and silver mineralization, covering approximately 62,300 hectares with a history of drilling and exploration and multiple high-priority targets. In Canada, Lancaster's assets include the Lac Iris Polymetallic Project in Quebec's James Bay region and the Piney Lake Gold Project in Saskatchewan. Lancaster's portfolio provides exposure to gold, silver, and polymetallic exploration opportunities across tier-one jurisdictions.Andrew Watson, President & Chief Executive Officer,Lancaster Resources Inc.Andrew@Lancaster-Resources.comTel: (604) 923-6100www.lancaster-resources.comThe Canadian Securities Exchange has not reviewed, approved nor disapproved the contents of this news release. Cautionary Statement Regarding Forward-Looking StatementsCertain statements contained in this press release constitute forward-looking information. These statements relate to future events, or Lancaster's future performance. The use of any of the words "could", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on Lancaster's current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, the ability of Lancaster to execute its exploration plans, raise capital, retain key personnel, identify, acquire, explore, and develop high-quality mineral-rich properties constitute forward-looking information. Actual results and developments may differ materially from those contemplated by forward-looking information. Readers are cautioned not to place undue reliance on forward-looking information. The statements made in this press release are made as of the date hereof. Lancaster disclaims any intention or obligation to publicly update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as may be expressly required by applicable securities laws.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/286260 Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

5 3 月, 2026

CMS(867.HK/8A8.SG): Self-Developed INHBE-Targeting siRNA Drug Received IND Approval for Overweight/Obesity

SHENZHEN, CHINA, Mar 5, 2026 - (ACN Newswire via SeaPRwire.com) - China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that self-developed innovative drug INHBE-targeting small nucleic acid drug CMS-D008 injection (“CMS-D008”) received the Drug Clinical Trial Approval Notice issued by National Medical Products Administration (“NMPA”) on 4 March 2026. The NMPA has approved the conduct of clinical trials of CMS-D008 injection for overweight or obese individuals.About CMS-D008CMS-D008 is a novel siRNA therapy administered by subcutaneous injection. CMS-D008 targets and reduces the hepatic expression of the inhibin subunit beta E (INHBE) gene and lowers the level of Activin E protein encoded by INHBE, which blocks Activin E-ALK7 signaling and reduces fat accumulation effectively. Preclinical studies suggested that CMS-D008 efficiently and sustainably suppressed INHBE expression. In the diet-induced obesity model, CMS-D008 enhanced weight loss by reducing fat mass while retaining lean mass with a good safety profile. It demonstrates potentially better prospects for high-quality, long-term weight loss that boosts fat-specific loss while preserving muscle mass. In the future, it may be developed for the treatment of overweight/obesity, abdominal obesity, and related metabolic diseases.Fat Loss, muscle preserved: a potentially better therapeutic option for overweight/obesity Overweight or obesity is a chronic, progressive, relapsing disease characterized by excessive accumulation or abnormal distribution or function of body fat[1]. World Obesity Atlas 2025 Report projected that the global proportion of overweight and obese adults will rise to 50%, with nearly 3 billion adults impacted by high body mass index (BMI), and the population of adults who are overweight or obese in China is projected to reach 515 million by 2030[2]. Existing GLP-1RAs have been proven to be effective for the treatment of overweight and obesity. The main actions of GLP-1RAs are to suppress appetite by acting on the central nervous system and to delay gastric emptying[3]. INHBE’s novel mechanism of action differs from GLP-1RAs. INHBE is identified through genome-wide association studies. Populations with loss of function in INHBE are associated with favorable fat distribution and beneficial metabolic characteristics[4]. Targeted inhibition of INHBE might be more conducive for long-term weight management at the genetic level with precisely lower visceral fat and favorable metabolic profiles.CMS-D008 teams up with CMS-D005: highly effective weight loss plus long-term maintenance, building a more comprehensive weight-loss solutionCMS-D008 will synergize with CMS-D005, a self-developed innovative drug currently in clinical development. CMS-D008 reduces fat without sacrificing muscle mass by precisely inhibiting INHBE gene expression; while CMS-D005, as a GLP-1R/GCGR dual agonist, can effectively reduce liver fat while losing weight. The synergy between these two drugs will achieve highly effective weight loss benefits and long-term maintenance of results, jointly enhancing the Group’s R&D capabilities and product competitiveness in the field of obesity/metabolic treatment. Furthermore, leveraging the Group’s mature network resources in the field of cardiovascular and metabolic diseases, the drug’s R&D and commercialization process will be accelerated, providing patients with more comprehensive and innovative treatment options.The Group is actively preparing to initiate relevant clinical trials and strives to launch the Product as soon as possible.About CMSCMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs.CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients.CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development in its advantageous specialty fields, strengthening the competitiveness of the cardiovascular-kidney-metabolic/ gastroenterology/ ophthalmology/ skin health businesses, bringing economies of scale in specialty fields. Among them, the skin health business (Dermavon) has become a leading enterprise in its field, and is proposed to be listed independently on the SEHK. Meanwhile, CMS continuously promotes the operation and development of its integrated R&D, manufacturing and commercialization chain in Southeast Asia and the Middle East, capturing growth opportunities in emerging markets to support the high-quality and sustainable development of the Group.Reference:1. Chinese Society of Endocrinology. Guideline for chronic weight management and clinical practice of anti-obesity medications(2024 version). Chinese Journal of Endocrinology and Metabolism. 2024,40(7):545-564.2. World Obesity Federation. World Obesity Atlas 2025. London: World Obesity Federation, 2025. https://data.worldobesity.org/publications/?cat=233. Zhikai Zheng, Yao Zong, Yiyang Ma, Yucheng Tian, Yidan Pang, Changqing Zhang, Junjie Gao. Glucagon-like peptide-1 receptor: mechanisms and advances in therapy. Sig Transduct Target Ther 9, 234 (2024). doi: 10.1038/s41392-024-01931-z4. Parsa Akbari, Olukayode A Sosina, Jonas Bovijn, et al. Multiancestry exome sequencing reveals INHBE mutations associated with favorable fat distribution and protection from diabetes. Nat Commun.2022 Aug 23;13(1):4844. doi: 10.1038/s41467-022-32398-7.CMS Disclaimer and Forward-Looking StatementsThis press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert.This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections.Media ContactBrand: China Medical System Holdings Ltd.Contact: CMS Investor RelationsEmail: ir@cms.net.cnWebsite: https://web.cms.net.cn/en/home/ Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

5 3 月, 2026

Core Concepts Physiotherapy Partners with Podiatry Quest to Deliver Enhanced Assessments for Patients with Plantar Fasciitis

SINGAPORE, Mar 5, 2026 - (ACN Newswire via SeaPRwire.com) - Core Concepts Physio, one of Singapore's leading physiotherapy providers, has announced an expanded collaborative programme with podiatry service provider, Podiatry Quest, to offer enhanced, multidisciplinary assessments for patients experiencing plantar fasciitis and stubborn heel pain.Plantar fasciitis remains one of the most common and persistent causes of heel pain among adults, especially those with active lifestyles or occupations involving long hours on their feet. Often treatment seeks to address only one aspect of the condition rather than the full movement chain, which leads to recurring pain as other aspects remain unresolved.To bridge this gap, the two clinics have formalised a joint assessment pathway that evaluates plantar fasciitis from both the top-down (physiotherapy) and the bottom-up (podiatry) so as to ensure that no contributing factor is overlooked.A Smarter, More Complete Way to Diagnose Heel PainPhysiotherapy and podiatry traditionally manage different elements of plantar fasciitis. Physiotherapists focus on mobility, strength, gait and load tolerance, while podiatrists address foot posture, footwear, ground forces and orthotic support.The new integrated pathway combines both perspectives into a single, coordinated evaluation which results in:More accurate, holistic diagnosesFully optimised treatment strategiesFewer flare-ups and recurrencesClearer, consistent guidance for patientsFaster and more sustainable outcomes"Many patients struggle because plantar fasciitis isn't caused by just one issue," said Mr Chng Chye Tuan, Senior Principal Physiotherapist at Core Concepts Physiotherapy. "It's a movement chain problem involving the foot, calf, ankle mobility, daily load and footwear. When physiotherapists and podiatrists work together, we address every contributing factor — not just the symptoms."A Case Study Demonstrating Collaborative SuccessIn a recent case, a 42-year-old recreational runner sought help after six months of persistent heel pain. Physiotherapy improved his morning pain and running tolerance, but he continued to experience flare-ups following long work shifts.A podiatry assessment revealed prolonged pronation, footwear-related loading issues and inadequate shock absorption. With customised orthoses and tailored footwear recommendations, the patient's daily load decreased significantly — allowing physiotherapy progress to continue without setbacks.Within 10 weeks of coordinated care, he achieved pain-free mornings, comfortable workdays and full return to running."This case reflects what we see frequently," said Mr Yeo Boon Kiak, Principal Podiatrist at Podiatry Quest. "Physiotherapy builds tissue capacity, strength and movement control. Podiatry reduces unnecessary strain and optimises how forces enter the foot. When combined, this creates the ideal environment for long-lasting recovery."Making Multidisciplinary Care Accessible NationwideThrough this collaboration, patients with plantar fasciitis now benefit from:Joint physiotherapy–podiatry assessmentsAligned clinical decision-makingConsistent communication across providersA thorough evaluation of both the cause and consequence of heel painA fully optimised recovery pathway"Our multidisciplinary team brings together the best of both professions," said Mr Chng Chye Tuan. "Whether someone is a runner, a frequent traveller or stands long hours at work, this collaboration ensures their care is comprehensive, precise and built around their real-life demands."About Core Concepts PhysiotherapyCore Concepts Physio is one of Singapore's largest private physiotherapy groups, offering evidence-based musculoskeletal and sports physiotherapy across multiple clinic locations. Their multidisciplinary approach allows clients to benefit from integrated care, ensuring complete and effective recovery. Know more please contact marketing@coreconcepts.com.sg or call +65 62263632 or visit our office at 6 Raffles Quay, #11-01, Singapore 048580.About Podiatry QuestPodiatry Quest specialises in diagnosing and treating foot, ankle and lower limb conditions. Led by experienced podiatrists, the clinic offers services such as customised orthoses, biomechanical assessments, gait analysis and comprehensive podiatric care.Contact DetailsOrganization: Core Concepts Pte LtdContact: Clemence LimWebsite: https://www.coreconceptsphysio.sg Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

5 3 月, 2026

FinHarbor Completes Core Deployment of Hybrid Neobank Platform for Asterium in Uzbekistan

Tashkent, Uzbekistan, Mar 5, 2026 - (ACN Newswire via SeaPRwire.com) -�FinHarbor, a modular financial infrastructure provider, has completed the core phase of a hybrid neobank platform for Asterium � a licensed fintech project in Uzbekistan that combines traditional banking with digital asset services under a single regulated framework.Why Uzbekistan - Uzbekistan is actively building a regulated environment for digital assets. The country has introduced a national distributed ledger system (Mirasmanda) and a state-backed digital asset (HUMO), supervised by the National Agency for Perspective Projects (NAPP). For infrastructure providers, this creates a rare opportunity: a market where crypto and banking can coexist within a clear legal perimeter.Asterium's project is designed to operate fully within this framework.What Was Deployed - FinHarbor adapted its microservices-based platform to the requirements of the Uzbek market and Asterium's business model. The core deployment covers three key layers:Banking infrastructure � management of fiat accounts, issuance of physical and virtual bank cards (VISA, MasterCard, HUMO), and integration with local processing systems.Digital asset infrastructure � crypto account management, integration with Bitcoin, Ethereum, and Tron networks, as well as native connection to Uzbekistan's Mirasmanda ledger for HUMO asset support.Compliance and exchange � a unified KYC/KYB/AML/KYT module aligned with local and international standards, integration with global AML/KYT providers, and multiple exchange models including fiat-to-crypto, crypto-to-fiat, and crypto-to-crypto conversions with card-based ramp-in and ramp-off.The result is a single platform where users can hold bank accounts and crypto wallets, exchange assets, and use cards � all within a regulated environment.How the Partnership Works - FinHarbor operates as Asterium's strategic technology partner, not just a software vendor. A dedicated implementation team supports the platform on an ongoing basis, managing feature rollouts and infrastructure expansion."This project required deep architectural customization � from integrating with a national blockchain system to building compliance workflows that satisfy both local regulators and international standards," said Ilya Podoynitsyn, CEO of FinHarbor. "The core phase is complete, and we are already scaling the platform with new products and business use cases."��What's Next - With the core infrastructure live, FinHarbor and Asterium are moving into the next stage: launching consumer-facing products and expanding the platform's functionality to support additional business lines built on the deployed stack.About FinHarborFinHarbor provides modular technology infrastructure for launching compliant financial products � from wallets and neobanks to crypto ramps and OTC desks. The platform supports fiat, crypto, and hybrid business models, with ISO/PCI DSS-certified architecture and deployment options across Europe, MENA, and CIS markets.Social LinksLinkedIn: https://www.linkedin.com/company/finharbor/Blog: https://www.finharbor.com/blog�Media contactBrand: FinHarborContact: Media teamWebsite: https://www.finharbor.com/ Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

5 3 月, 2026

Formerra Appoints Tom Kelly as Chief Executive Officer

CLEVELAND, Ohio, Mar 4, 2026 - (ACN Newswire via SeaPRwire.com) - Formerra, LLC ("Formerra"), a leading distributor of engineered thermoplastic resins, additives, elastomers, and other specialty materials, today announced the appointment of Tom Kelly as Chief Executive Officer ("CEO"). A seasoned executive with over 30 years of specialty and engineered materials experience, Tom is known for leading teams to drive differentiated growth and building high-performing organizations set up for long-term success. The former CEO, Cathy Dodd, will stay on as Special Advisor to the Board and will remain an investor in the Company.Tom brings extensive commercial, supply chain, and distribution experience with a strong background in scaling global enterprises in the engineered materials sector. After previous roles at Cabot Microelectronics and Chemtura, Tom's most recent role was Senior Vice President of Engineered Materials at Celanese, where he led key commercial and operational initiatives across engineered polymers and specialty segments. He brings a strong blend of leadership, industry insight, and supply-chain expertise to his new role as CEO of Formerra."Formerra has built a tremendous reputation as a technical selling organization and for putting customers first, supported by exceptional people and supplier partners in the engineered materials ecosystem," said Tom Kelly. "I'm excited about the opportunity to build on its strengths and accelerate capabilities in new geographies and adjacent materials. We will continue investing in our people, distribution network, and in our product line card to strengthen Formerra's competitive position globally."About FormerraFormerra, headquartered in Cleveland, Ohio, is a leading distributor of engineered thermoplastic resins, additives, elastomers, and other specialty materials. Formerra supports leading blue-chip customers and suppliers with its extensive specialty materials portfolio and value-added combination of commercial and technical expertise, global market knowledge, and industry-leading logistics and service capabilities. Formerra offers highly specialized technical, processing, design and regulatory support for critical end market applications in the healthcare, consumer, industrial and mobility markets. Formerra operates an asset-light network of 37 warehouses and 21 bulk transfer stations located in North America, Central America, Europe, and Asia.Media ContactJackie MorrisMarketing Communications Manager, Formerrajackie.morris@formerra.com+1 630-972-3144SOURCE: Formerra Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

4 3 月, 2026

Hong Kong International Jewellery Show opens today showcasing global designs and trends

HONG KONG, March 4, 2026 - (ACN Newswire via SeaPRwire.com) – The 42nd Hong Kong International Jewellery Show, organised by the Hong Kong Trade Development Council (HKTDC), opens today at the Hong Kong Convention and Exhibition Centre (HKCEC) and runs for five consecutive days until 8 March. It is held concurrently with the 12th Hong Kong International Diamond, Gem & Pearl Show which opened on Monday (2 March) at AsiaWorld-Expo and concludes on 6 March. The two shows bring together some 4,000 exhibitors from over 40 countries and regions, forming the world’s largest one-stop jewellery marketplace.Jenny Koo, Deputy Executive Director of the HKTDC, said: “Alongside the expanded Hall of Fame, the show will feature the debut of the Hard Pure Gold Pavilion and the Hong Kong Watch Manufacturers Association Pavilion. Furthermore, Uzbekistan is participating for the first time with a delegation of 10 companies, showcasing a wide range of gold jewellery. Through diversified exhibit profiles, we aim to create more collaboration opportunities for the industry and reinforce Hong Kong’s status as a global jewellery trading hub.”Kent Wong, Chairman of the Hong Kong International Jewellery Show and the Hong Kong International Diamond, Gem & Pearl Show Fair Organising Committee, said: “Hong Kong is an international trade and sourcing centre and our twin jewellery shows play a pivotal role. Continuing the successful ‘Two Shows, Two Venues’ format, the fairs attract global jewellery professionals for sourcing and networking, helping the industry capture the latest global market trends.”International brands converge, key zones expandAt the Hong Kong International Jewellery Show, the Hall of Fame has expanded by over 40%, welcoming more renowned international jewellery brands. Among them, Turkish exhibitor Hosgor Kuyumculuk Mucevherat Ticaret Limited Sirketi (Booth: CEC 3B-D15) presents a 35.5-carat diamond necklace that combines exquisite craftsmanship with brilliant radiance. Another highlight is the Hall of Extraordinary, which features exhibitors such as Hong Kong’s Glamour Fine Jewelry Enterprise Company (Booth: CEC GH-C16), showcasing a bracelet featuring Colombian emeralds paired with diamonds and rubies in a radiant and luxurious style.New pavilions highlight oriental aestheticsWith hard pure gold technologies gaining popularity in the Chinese Mainland, the Hard Pure Gold Pavilion (Booth: CEC 3E-F02) features 11 exhibitors organised by the World Gold Council. The pavilion showcases innovative techniques that produce harder, lighter and brighter gold pieces capable of setting a variety of gemstones. Also, the Hong Kong Watch Manufacturers Association Pavilion highlights crossover craftsmanship between jewellery setting and watchmaking.The fairs also feature several events celebrating oriental aesthetics. Today, the Jewellers’ and Goldsmiths’ Association of Hong Kong Limited presented the awards for the Hong Kong International Fashion Chuk Kam Jewellery Design Competition. The competition encourages designers to create culturally rich and commercially viable gold jewellery for the ASEAN and the Middle East markets. Tomorrow (5 March) will see the awards presentation of the inaugural International Fei Cui Jewellery Design Competition, organised by the Hong Kong Jade Association, honouring designers who skilfully blend jadeite with global cultural elements.Antique treasures and cutting-edge designAntique jewellery remains highly sought-after by collectors and high-end customers for its historical value and craftsmanship. The Antique & Vintage Jewellery Galleria presents an array of rare pieces, including a bi-colour enamel diamond piece from World Coins Co., Ltd. (Booth: CEC CH-N12), with a history spanning over a century. Design pieces are equally captivating, the Designer Galleria welcomes 10 Korean designers this year. Together with the Young Jewellery Designer Arena, participated by the Asia Pacific Creator Association and the Asia Jewelry Culture Design and Crafts Association, about 50 designer exhibitors will showcase their diverse creativities in the fairground.The HKTDC continues to nurture local talents in the jewellery industry. In partnership with the Jewellers’ and Goldsmiths’ Association of Hong Kong Limited, Hong Kong Jewellery & Jade Manufacturers Association, Hong Kong Jewelry Manufacturers’ Association, and Diamond Federation of Hong Kong, the 27th Hong Kong Jewellery Design Competition returns under the theme “Pure Elegance – Natural Beauty”, offering a stage for local professional designers and students. The awards ceremony will be held tomorrow (5 March) at the HKCEC, with winning pieces on display to demonstrate innovative design.E-commerce and technology empower industry growthTo help exhibitors expand into the Chinese Mainland market and develop their online sales channels, the fairs continue the collaboration with Taobao Tmall. For the first time, the fairs also welcome Douyin, partnering with influencers and KOLs for on-site live streaming to promote exhibitors’ products. On 7 March, a seminar will feature experts discussing the latest online marketing trends and tactics.Another seminar on 5 March will explore how AI and new technologies enhance competitiveness, optimise production, and drive product innovation in the jewellery industry.Engaging events to connect and inspireA diverse lineup of events will be held to foster industry dialogue. These include a seminar by Dr Jack Ogden, a distinguished British historian and jewellery authority, who will analyse the evolution of jewellery craftsmanship and changing aesthetic tastes throughout history. The jewellery parades will highlight themes such as intangible cultural heritage jewellery, curated selections from the Antique & Vintage Jewellery Galleria, as well as highlights from the Hall of Extraordinary, Designer Galleria, and gold jewellery.Full list of the winning entries from Hong Kong International Fashion Chuk Kam Jewellery Design Competition: https://bit.ly/46B5edLPhoto download: https://bit.ly/46GadtLThe 42nd Hong Kong International Jewellery Show opens today at the HKCEC, alongside the 12th Hong Kong International Diamond, Gem & Pearl Show at AWE, together gathering around 4,000 exhibitors from over 40 countries and regionsAnthony Lam, Chairman of the Federation of Hong Kong Industries (front row, centre); Bernard Chan, Under Secretary for Commerce and Economic Development (front row, fifth right); Sophia Chong, Executive Director of the HKTDC (front row, fifth left); Kent Wong, Chairman of the HKTDC twin jewellery shows’ Fair Organising Committee (front row, fourth right); Winston Chow, Chairman of the HKTDC Jewellery Advisory Committee (front row, fourth left), and other officiating guests attended today’s networking receptionThe Hall of Fame has expanded by over 40% this year, featuring more international brandsThe World Gold Council debuts the Hard Pure Gold Pavilion, featuring 11 exhibitors to showcase innovative hard pure gold craftsmanship to international buyersThe Hong Kong Watch Manufacturers Association Pavilion makes its first appearance, exhibiting luxury timepieces that integrate jewellery setting craftsmanshipShenzhen Meifei Precious Metals Co Ltd (Booth: CEC 3E-E02) presents 24K gold necklaces themed around oriental palatial and modern Chinese styles, employing six traditional gold techniquesHong Kong exhibitor Present Watch & Jewelry (Booth: CEC 1CON-019) showcases a diamond wristwatch inspired by the Northern Song masterpiece “Ode to the Lotus”, with a dial crafted to evoke a lotus pondTurkish brand Zen Diamond (Booth: CEC 3B-C12), which appointed global celebrity Jennifer Lopez as its ambassador in 2025, presents a series of diamond pieces at the showHong Kong designer Austy Lee (Booth: CEC 1EF32) launches a zebra-inspired-bangle for the Year of the HorseWinners of the Hong Kong International Fashion Chuk Kam Jewellery Design Competition pictured at the award ceremony with distinguished guestsFair detailsHong Kong International Jewellery ShowDateOpening hours4 March (Wednesday)10:30am to 6:30pm5-7 March (Thursday to Saturday)10am to 6:30pm8 March (Friday)10am to 5:30pmVenueHong Kong Convention and Exhibition Centre, 1 Expo Drive, Wan ChaiPress registration and Media CentreMedia representatives can register at the entrance of HKCEC Hall 1D Concourse, or at the HKTDC Media Centre (G/F, Expo Drive Entrance, HKCEC) by presenting a business card or media identification.* Hong Kong International Diamond, Gem & Pearl ShowDateOpening hours2 March (Monday)10:30am to 6:30pm3-5 March (Tuesday to Thursday)10am to 6:30pm6 March (Friday)10am to 5:30pmVenueAsiaWorld-Expo, Hong Kong International Airport, Lantau, Hong KongPress registration and Media CentreMedia representatives can register at the entrance of AsiaWorld-Expo’s East Lobby (Next to Hall 5) or at the Media Centre (Room 201C, 2/F) by presenting a business card or media identification.** For security reasons, all media will be required to present a name card and identity card (or passport) for press registration. Individuals with a valid press pass will be required to present their identity card (or passport) again at the entrance to the exhibition halls for identity verification. Please allow sufficient time for registration and admission.Websites Hong Kong International Jewellery ShowHong Kong International Diamond, Gem & Pearl ShowWebsitehttp://hkjewelleryshow.hktdc.comhttp://hkdgp.hktdc.comActivity listhttps://www.hktdc.com/event/hkjewellery/en/intelligence-hubhttps://www.hktdc.com/event/hkdgp/en/intelligence-hubShuttle bus arrangementshttps://www.hktdc.com/event/hkjewellery/en/travel-to-fairground-hkcechttps://www.hktdc.com/event/hkdgp/en/travel-to-fairground-aweHKTDC Media Room: https://mediaroom.hktdc.com/enMedia enquiriesPlease contact the HKTDC’s Communications & Public Affairs Department:Winnie KanTel: (852) 2584 4055Email: winnie.wy.kan@hktdc.orgKaty WongTel: (852) 2584 4524Email: katy.ky.wong@hktdc.orgJane CheungTel: (852) 2584 4137Email: jane.mh.cheung@hktdc.orgAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in the Chinese Mainland, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels.  Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

4 3 月, 2026

BASIS Accelerates Platform Development Following $35M Capital Injection

LONDON, Mar 4, 2026 - (ACN Newswire via SeaPRwire.com) - BASIS has announced a significant acceleration in platform development following its recent $35 million Pre-Series A capital raise. The funding enables parent company Base58 Labs to advance the commercial integration of its proprietary Base58 Hyper-Latency Engine (BHLE) into the BASIS staking infrastructure.BHLE, developed over multiple years within institutional high-frequency trading (HFT) research environments, is now transitioning from research phase into structured platform deployment. The engine is designed to enhance execution efficiency, reduce latency-related inefficiencies, and optimise liquidity management across fragmented digital asset markets.Industry observers note that the integration of institutional-grade execution frameworks into a staking infrastructure model represents a strategic evolution within the broader digital asset ecosystem. While detailed technical specifications remain confidential, Base58 Labs confirmed that BHLE will serve as a core execution layer within the BASIS architecture.In parallel with the technical acceleration, Base58 Labs has initiated a large-scale recruitment programme across Europe and the United Kingdom. The company is onboarding quantitative engineers, blockchain systems architects, and regulatory compliance specialists, all of whom will focus exclusively on BASIS platform development and infrastructure scaling.“Our objective is to combine years of proprietary research with expanded operational capacity,” a company spokesperson stated. “The recent capital raise enables us to consolidate technical, intellectual, and human resources around a single mission: delivering a high-performance staking infrastructure aligned with institutional standards.”BASIS is also being developed with regulatory alignment in mind, including adherence to emerging European frameworks such as MiCA (Markets in Crypto-Assets). The platform aims to provide a structurally robust environment for both institutional and retail participants.With liquidity reserves strengthened and integration milestones progressing, BASIS remains on track for an official launch in the second half of 2026.About Base58 LabsBase58 Labs is a London-based digital infrastructure company specialising in high-performance execution technologies and blockchain optimisation systems. Learn more: https://base58labs.com/Media ContactBase58 Labs PR TeamEmail: info@base58labs.comBASIS Official Website: https://basis.pro/Base58 Labs Official Website: https://base58labs.com/ Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

4 3 月, 2026

Thailand RISE Fund Positions Thai Research for Global Innovation Impact

BANGKOK, Mar 4, 2026 - (ACN Newswire via SeaPRwire.com) - Thailand has launched a new phase in its national research and innovation strategy with the introduction of the Thailand RISE Fund, a rebranded national research funding initiative aimed at accelerating the transition from academic research to real-world economic and social impact.The initiative was highlighted at the Thailand RISE Fund Forum: RISE UP THAILAND, hosted in collaboration with Chulalongkorn University. The national forum brought together policymakers, researchers, industry leaders, and innovation stakeholders to explore how Thailand can strengthen its position in the global innovation economy.From Research Output to Real-World ImpactThailand’s research performance has expanded significantly over the past decade, but national leaders say the country’s next challenge is ensuring that research delivers tangible benefits.Professor Dr. Wilert Puriwat, President of Chulalongkorn University, emphasized the importance of translating knowledge into national progress. “A country advances not simply because it produces knowledge, but because it can transform knowledge into a coordinated system that connects policy, research, innovation, and industry,” he said.He added that universities must play a strategic role in national development. “Our goal is to move research beyond the laboratory and into real-world applications that deliver measurable economic and social benefits while strengthening Thailand’s long-term competitiveness.”Building a National Innovation SystemNational research leaders stressed that Thailand’s science and innovation system must operate with clearer direction and stronger coordination.Professor Dr. Sompong Klaynongsruang, President of Thailand Science Research and Innovation (TSRI), said collaboration across sectors is essential. “The development of Thailand’s science, research and innovation system must be driven systematically—from strategic policy and targeted funding to the practical use of research outcomes in the economy and society.”She noted that cooperation among universities, government agencies, and the private sector will be key to achieving long-term impact. “When all sectors move forward together, research will not only generate knowledge but also create meaningful national transformation.”More Than a RebrandingThe transition to the Thailand RISE Fund represents a strategic shift in how Thailand supports research and innovation.Asst. Professor Dr. Ake Pattaratanakun, Chairman of Thailand RISE Fund Strategic Communications Subcommittee, said the initiative reflects a new national priority. “Thailand has significantly increased its research output over the past decade, but the key challenge today is not quantity. It is how research creates economic and social value.”He explained that the Thailand RISE Fund is designed to bridge the gap between research and industry. “Thailand RISE Fund is intended to serve as a systemic intermediary, linking research to real economic needs and focusing on proof of impact rather than publication numbers.”Four Pillars of the RISE FrameworkThe Thailand RISE Fund operates under a strategic framework built on four pillars:ResearchInnovationScience ExcellenceEcosystemThe ecosystem pillar emphasizes partnerships among universities, businesses, government agencies, and communities to support a comprehensive innovation economy.Expanding Opportunities NationwideThe Thailand RISE Fund is also expanding engagement across Thailand to ensure broader participation in the innovation system. Regional forums and outreach activities are designed to help researchers and entrepreneurs develop collaborative projects aligned with local economic strengths. This approach reflects a shift from centralized funding toward a more inclusive and distributed innovation ecosystem.Research for National DevelopmentThe Thailand RISE Fund aims to transform the role of research in Thailand’s development strategy. “Our vision is to move Thai research from ‘research for journals’ to ‘research for the nation,’” Dr. Ake said.By focusing on measurable impact and long-term value creation, the initiative seeks to strengthen Thailand’s competitiveness while supporting sustainable economic and social development.For more information, please contact pr@tsri.or.th#ThailandRiseFund Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

4 3 月, 2026

JCB, with Resona, to Commercialize Ultra-Wideband (UWB) Payments

TOKYO, Mar 4, 2026 - (ACN Newswire via SeaPRwire.com) - JCB Co., Ltd. (JCB), together with Resona Holdings, Inc. (Resona; TSE: 8308), announced the start of a project to commercialize ultra-wideband (UWB) payments that realize a new purchasing experience using UWB communication.The two companies have agreed to launch the world's first full-scale project for the practical application and commercialization of UWB payments. In 2026, JCB will work with multiple technology partners and collaborating merchants to demonstrate payment technology and value-added solutions for merchants, as well as user experience building projects to create new purchasing experiences. On top of that, JCB aims to launch small-scale commercial operations in 2027 and full-scale commercialization in earnest in 2028.The two companies are participating in the FiRa® Consortium, which standardizes and contributes to the development of UWB communication technology, as well as builds new payment experiences and value-added solutions for stores using UWB technology.About the UWB Payment ProjectThrough the activities of the FiRa Consortium, JCB, and Resona will standardize technologies and experiences for payment applications, and with the support of FiRa Consortium’s participating vendors, conduct technology tests. From 2026, the two companies will demonstrate UWB payments and value-added solutions together with multiple partner merchants and provide feedback to FiRa on the necessary technology development.In parallel, JCB and Resona will conduct research on user experience and store payment operations to confirm user and merchant acceptability.Moreover, to reduce the introduction load for merchants as much as possible, the project aims to build a payment infrastructure that can widely accept payment solutions using UWB from competitors. The project is aimed to launch on a small scale in 2027 and commercialize on a full-scale in 2028.In addition, the two companies will aim to realize new UWB payments through collaboration with a wide range of partners in Japan and other countries.Image of UWB paymentThe Background of This ProjectUWB communication technology is a short-range wireless communication technology that has the characteristics of (1) accurate location of devices and (2) high-speed data communication and is being used in Japan and overseas for location verification of digital keys for cars and homes, indoor navigation, and tags.The technology is also used overseas in gateless public transportation systems. In the future, it is expected to be used for payments, as with NFC (Near Field Communication) and QR codes.Outside Japan, the spread of smartphones with UWB functions has been slow, but in Japan, smartphones that can use UWB communication are widely available, and can be utilized in advance of the rest of the world. Moreover, the diversification of cashless payments and the wide range of value-added solutions for users and stores are also characteristics of Japan's payment scene. The project believes that it is necessary to take advantage of this location and create new payment solutions to solve problems for users and stores and meet the needs of new solutions.Overview of “UWB Payments”UWB payments can greatly improve the purchasing experience. Until now, it has been necessary to physically touch a card or smartphone at a payment terminal in a merchant or to scan a QR code. UWB payments will leverage short-range communication characteristics to create a new purchasing experience, such as hands-free payments even with a smartphone in a pocket or bag, and to instantly convey user information, such as diet restrictions, to merchants.Also, by utilizing the accurate location information of smartphones, it is possible to realize value-added solutions for both users and merchants that have never been seen before, such as improving the efficiency of navigation and waiting in stores, distributing personalized advertisements and coupons using smart displays, and providing new customer service for VIP customers. It is expected to be used not only to improve the experience but also to be used as a labor-saving solution to address labor shortages.Comparison of NFC and UWB paymentsExamples of value-added solutions:Provide communication functions for both users and merchants. For example, it can be used to automate the communication of requests such as food allergy information, whether or not plastic bags are needed, whether receipts are present and addressed, loyalty program information, whether coupons are available and used, and requests such as handicap and assistance needs, and children's chair preparations.Provide special customer service experiences for VIP customers and support store operations. Customers can receive a special customer service experience without verbally communicating with the merchant’s staff, allowing stores to provide appropriate customer service based on specific customer needs.Enable 1-to-1 marketing capabilities for customers. Marketing utilization, such as displaying personalized information on smart displays near customers, distributing coupons to customers, and displaying personalized pricing.Past UWB Payments InitiativesIn January 2024, JCB and Resona entered into a strategic partnership for the "Hands-free Payment" project, an initiative to build a new payment experience that does not require smartphone operation using device-to-device communication technology. Using UWB communication technology by linking the smartphones held by customers who visit the store with payment terminals and various IoT devices installed in the store, it allows customers to complete the payment process from authentication to payment procedure without taking out a smartphone or activating the screen, and even keeping their smartphone in their bag or pocket. By utilizing this solution, customers can grasp information at the time of their visit to the store and receive customer service and new in-store experiences, such as providing services for VIPs, preferential treatment, and coupon distribution.JCB also announced the development of a UWB-enabled app for iPhones and Apple Watches to support the project, along with a reference model of store checkout equipment and the launch of user testing. Through these efforts, JCB and Resona have been discussing and collaborating with their collaborative partners on technologies and business models.Looking ahead, JCB and Resona will work with multiple technology partners and collaborating merchants to carry out proof-of-concept initiatives for payment and merchant value-added solutions in 2026, with a phased commercial rollout planned for 2027 and full-scale commercialization targeted for 2028.About FiRa ConsortiumThe FiRa Consortium is a member-driven organization dedicated to transforming the way we interact with our environment by enabling precise location awareness for people and devices using the secured fine-ranging and positioning capabilities of Ultra-Wideband (UWB) technology. FiRa does this by driving the development of technical specifications and certifications, advocating for effective regulations, and defining a broad set of UWB use cases. To learn more about UWB and the FiRa Consortium, visit www.firaconsortium.org.About Resona Holdings, Inc.With the Group's purpose of "Making the future positive with finance +," we continue to take on the challenge of transformation and creation in order to transform the future into a positive one with ideas that go beyond the framework of finance. Adhering to our basic stance of "customer joy is Resona's joy," we will work to "strengthen value creativity" and "next-generation management infrastructure" to respond to customers and local communities.About JCB Co., Ltd.JCB is a major global payment brand and a leading credit card issuer and acquirer in Japan. JCB launched its card business in Japan in 1961 and began expanding worldwide in 1981. Its acceptance network includes about 71 million merchants worldwide. JCB Cards are now issued mainly in Asian countries and territories, with more than 175 million cardmembers. As part of its international growth strategy, JCB has formed alliances with hundreds of leading banks and financial institutions globally to increase its merchant coverage and cardmember base. As a comprehensive payment solutions provider, JCB is committed to delivering responsive, high-quality products and services to all customers worldwide.For more information, please visit: www.global.jcb/en/ContactAnna TakedaJCB Corporate CommunicationsTel: +81-3-5778-8353Email: jcb-pr@info.jcb.co.jp Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

4 3 月, 2026

OMP Unveils Decision-Centric Planning to Accelerate Supply Chain Decision Velocity

ANTWERPEN, BELGIUM, Mar 3, 2026 - (ACN Newswire via SeaPRwire.com) - OMP, a leading provider of AI-powered supply chain planning solutions, launches Unison Decision-Centric Planning, a new approach that helps organizations move from reactive, process-driven planning to proactive, event-driven decision-making.Built on OMP's flagship Unison Planning™ platform, Unison Decision-Centric Planning combines advanced AI, autonomous agents, real-time scenario modeling, and human validation to accelerate decision velocity. The approach enables organizations to anticipate disruption, evaluate trade-offs, and act with confidence in increasingly volatile supply chain environments.From reactive to proactive supply chain planningTraditional planning cycles are often too slow to keep pace with today's volatility. Unison Decision-Centric Planning replaces static, process-driven planning with a dynamic, decision-first approach that continuously senses change, identifies relevant scenarios, and quantifies business impact. By aligning AI-driven intelligence with human judgment, organizations move from reactive firefighting to proactive value optimization."With Unison Decision-Centric Planning, we help customers move beyond reactive firefighting," said Tom Wouters, Chief Product Officer at OMP."By combining human expertise with advanced AI and scenario modeling, we enable confident, proactive decisions that drive agility, resilience, and measurable business impact."Human-AI synergy for smarter, faster decisionsUnison Decision-Centric Planning leverages UnisonIQ to orchestrate AI agents, generative AI assistants, and advanced optimization engines. Routine manual tasks are automated, freeing planners to focus on cross-functional collaboration and decision-making. Explainable AI ensures transparency and trust, while autonomous agents continuously monitor supply chain signals and act in real time.Proven impact at Evonik OxenoEvonik Oxeno, a leading producer of C4 chemicals, partnered with OMP to transition from reactive planning to always-on, scenario-based decision-making. By leveraging real-time insights and simulations through Unison Planning, planners can anticipate disruptions and respond faster, improving agility and overall business performance."Unison Decision-Centric Planning has reinforced trust in the system among planners and executives. Scenario-based decision-making enables us to respond faster and improve company performance," said David Kochanek, Supply Chain Solution Manager at Evonik Oxeno."Scenario-based decision-making enables us to respond faster and improve company performance."Always-on decision intelligence at scaleUnison Decision-Centric Planning introduces event-driven agents that continuously assess opportunities or risks, aligning decisions with strategic and financial objectives. By running hundreds of scenarios, organizations can anticipate disruption, optimize outcomes, and achieve measurable gains in service levels, cost efficiency, sustainability, and decision velocity."Organizations can run hundreds of scenarios to prepare for disruptions and optimize outcomes."Learn more about decision-centric planningDiscover how decision-centric planning can transform your supply chain. Explore OMP's resources, including the always-on e-book and the full Evonik Oxeno success story. Learn more.About OMPOMP helps companies facing complex planning challenges to excel, grow, and thrive by offering the best digitized supply chain planning solution on the market. Hundreds of customers in a wide range of industries - spanning consumer goods, life sciences, chemicals, metals, paper, packaging, plastics - benefit from using OMP's unique Unison Planning™.Solution and product inquiriesContact OMPMedia inquiriesKira Perdue (Carabiner)SOURCE: OMP Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

3 3 月, 2026

MMG Announces 2025 Anuual Results, Record results, strong momentum

HONG KONG, March 3, 2026 - (ACN Newswire via SeaPRwire.com) – MMG Limited (“MMG”, stock code: 1208)  has today announced its 2025 Annual Results, delivering record revenue and profit. The exceptional result reflects disciplined operational and financial management, supported by favourable commodity prices.Watch the Message from CEO:https://drive.google.com/file/d/17KFqXpd_2sjdZDKfBBMBv1ee09Zic-e6/view'usp=drive_linkSafety is MMG’s first value and the Company recorded a Total Recordable Injury Frequency (TRIF) of 2.06 per million hours worked for the full year 2025. The Significant Events with Energy Exchange Frequency (SEEEF) was 0.80 per million hours worked, up slightly from 0.78 per million hours worked in 2024.Total earnings reached record highs. EBITDA rose to US$3,412.1 million, while EBIT increased to US$1,999.1 million. MMG also generated record net operating cash flow of US$2,689.5 million and free cash flow of US$1,608.1 million. Net profit after tax increased to US$955.2 million (US$509.4 million attributable to equity holders), up from US$366.0 million (US$161.9 million attributable to equity holders) in 2024.“We ended the year strongly, delivering an excellent finish in terms of our operational and financial performance,” said MMG’s CEO Ivo Zhao. “This included Las Bambas achieving their second-highest annual copper production, up 27 per cent from 2024, with records set for annual ore mined, ore milled and overall recovery rates.”MMG’s balance sheet is now substantially stronger, with reduced net debt and a gearing ratio at a record low of 33 per cent. This included the Las Bambas joint venture (JV) dividend payment, which facilitated the early repayment of US$500 million in Khoemacau borrowings. The remaining funds were used to repay other debts, deleverage the company’s balance sheet and support the early stages of Khoemacau's expansion.MMG’s total copper production rose 27 per cent year-on-year to 506,899 tonnes, driven by technology, innovation and stable operation across both pits at Las Bambas. Las Bambas contributed US$4,447.0 million in revenue (49 per cent year-on-year growth), contributing the largest share of the Group’s revenue growth. Total zinc production increased by six per cent to 232,060 tonnes, underpinned by a record year at Dugald River. Precious metals production at Rosebery also performed well.“While we remain mindful of the dynamic market environment, we are focused on delivering our growth plans and harnessing emerging technologies to drive long-term value for shareholders,” said Mr Zhao. “An important contribution to MMG’s growth pipeline is our Khoemacau Expansion project. Our plan is to increase annual production capacity to 130,000 tonnes of copper in copper concentrate by 2028, with the potential for 200,000 tonnes over time.”During 2025, the Company’s market capitalization exceeded HK$100 billion, including strong demand for its first convertible bond.MMG’s 2025 Annual Results Report is available here.Las BambasKhoemacauDugald RiverRoseberyKinseverePhoto download link: https://drive.google.com/drive/folders/1o9ArIgbJSAT2z1UCt8ttB69L9l9jiebx'usp=drive_linkAbout MMGFounded in 2009, MMG’s vision is to create a leading international mining company for a low carbon future. The company is headquartered in Melbourne, Australia and Hong Kong and Beijing, China and listed on the Hong Kong Stock Exchange (HKEX1208).MMG’s portfolio supports copper, zinc and cobalt production, with soon to be nickel – products that are critical to achieving global decarbonisation and electrification targets. With operations in Australia, Botswana, the Democratic Republic of Congo and Latin America, the company makes a direct contribution to the economic and social development of its host countries.In 2025, MMG released its first nature strategy and progressed a refresh of its climate strategy. MMG's membership of the UN Global Compact further aligns the company with global leaders on human rights, climate action, and governance. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

3 3 月, 2026

Concord New Energy Signs MOU with Bain Capital-Backed Bridge Data Centre

HONG KONG, March 3, 2026 - (ACN Newswire via SeaPRwire.com) – On 02 March 2026, Concord New Energy Group (“CNE Group”) signed a Memorandum of Understanding (MOU) in Singapore with Bridge Data Centres (BDC), a portfolio company of Bain Capital.Under the MOU, the parties will jointly explore diversified energy supply pathways integrating renewable energy and hydrogen solutions on a global basis to support the low-carbon transformation of data centre infrastructure. The collaboration includes the development of Singapore’s first barge-based hydrogen power generation solution designed specifically for artificial intelligence (AI) digital infrastructure.The partnership will encompass hydrogen power pathway studies, system integration design, energy storage deployment assessments, and optimization of power procurement mechanisms. Through these initiatives, both parties aim to enhance energy reliability, operational flexibility, and long-term sustainability for next-generation data centre campuses.CNE brings extensive expertise in renewable energy development and integrated energy systems, while BDC contributes leading operational capabilities in digital infrastructure. The collaboration is expected to accelerate the convergence of clean energy solutions and advanced computing infrastructure.As artificial intelligence and high-performance computing continue to reshape regional economies, this partnership will further support Singapore’s ambition to remain a leading digital hub powered by low-carbon energy.Bridge Data Centres (BDC)Headquartered in Singapore, Bridge Data Centres (BDC) is a leading hyperscale data centre platform in the Asia Pacific region backed by Bain Capital. The company focuses on the development and operation of high-performance digital infrastructure across multiple high-growth markets. BDC is committed to delivering resilient, reliable, and sustainable infrastructure solutions to support the rapid growth of cloud computing and artificial intelligence (AI) applications.Concord New Energy Group (CNE)Headquartered in Singapore, Concord New Energy Group is a renewable energy developer and operator listed on the Main Board of the Hong Kong Stock Exchange and the Singapore Exchange. With 20 years of experience in the renewable energy industry, CNE’s portfolio covers wind power, photovoltaic (PV) and energy storage projects. The Group has strong capabilities in project development, investment, construction and long-term asset management, and currently holds over 5GW of equity capacity globally. CNE remains committed to promoting the application of clean energy and providing integrated energy solutions to support sustainable development. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

3 3 月, 2026

Hua Medicine Announces the Approval of Dorzagliatin for Marketing in Hong Kong SAR, China

- First glucokinase-activator (GKA) approval outside mainland China- Approval supports a differentiated approach to Type 2 diabetes (T2D) management- Hong Kong will serve as Hua Medicine’s launchpad for international market expansionSHANGHAI, HONG KONG, Mar 3, 2026 - (ACN Newswire via SeaPRwire.com) – Hua Medicine ("the Company", Hong Kong Stock Exchange Stock Code: 2552.HK) announced today that its global first-in-class glucokinase activator (GKA) dorzagliatin (Trade name: MYHOMSIS(R)) has been approved for marketing by the Pharmaceutical Service of the Department of Health of the Hong Kong Special Administrative Region of China for the treatment of Type 2 diabetes in adults.Under Hong Kong's "1+" pharmaceutical regulatory innovation mechanism, the approval follows the acceptance of dorzagliatin’s New Drug Application (NDA) by the Hong Kong Department of Health in September 2025. As the first innovative drug for chronic metabolic diseases approved for marketing since the launch of "1+" mechanism, the successful rollout of dorzagliatin not only brings an entirely new treatment option for patients with Type 2 diabetes in Hong Kong, but also marks a crucial step in Hua Medicine's strategic layout to expand from China to the Southeast Asian and global markets with Hong Kong as its hub.Cao Beili, Vice President of Department of Corporate Operation and Great Bay Development of Hua Medicine, stated: “Among the three new drugs approved under the ‘1+’ mechanism, MYHOMSIS(R) is an innovative medicine developed in China that has obtained approval from the National Medical Products Administration (NMPA). It is also the first primary care drug product approved under the ‘1+’ mechanism.”Dr. Chen Li, Founder, Executive Director and CEO of Hua Medicine, stated: "The approval of dorzagliatin for marketing in Hong Kong is a significant milestone in the Company's development. As one of the first original innovative drugs to benefit from Hong Kong's '1+' mechanism, this achievement not only reflects Hong Kong's support for innovative drugs, but also validates the global competitiveness of China's independently developed innovative drugs. The launch in Hong Kong is a key step for Hua Medicine to enter the Southeast Asian and international markets. We will take Hong Kong as the hub to build a marketing network and R&D cooperation system radiating Southeast Asia and connecting the world, bringing China's independently developed innovative drugs to more diabetes patients in countries and regions around the globe. Meanwhile, we will continue to advance the marketing approval process of dorzagliatin in the Macao Special Administrative Region of China to achieve its full rollout in the Guangdong-Hong Kong-Macao Greater Bay Area, and relying on the regional advantages in mechanisms, talent and medical resources, we will advance the clinical expansion of new indications and the international promotion of MYHOMSIS(R)."Global First-in-Class & Local Clinical Data: Establishing a New Model for Restoring Glycemic Homeostasis in Diabetes TreatmentType 2 diabetes remains a progressive disease characterized by impaired glucose regulation and declining pancreatic β-cell function over time. While many therapies address downstream consequences of dysregulated blood glucose, dorzagliatin is a global first-in-class GKA innovative drug independently developed by Hua Medicine. Its core innovation lies in repairing the impaired function and expression of glucokinase (GK) in patients with Type 2 diabetes, thereby improving patients' glucose sensitivity from the source and ameliorating the imbalance of glycemic homeostasis. The drug acts on multiple key organs of glucose metabolism including the islets, intestines and liver, exerting a synergistic effect through multiple targets:- enhancing glucose-stimulated insulin secretion from pancreatic β-cells, - promoting GLP-1 release from intestinal L-cells, and - modulating hepatic glucose output through glycogen regulation.This coordinated, multi-organ profile differentiates dorzagliatin from existing oral antidiabetic therapies and reflects Hua Medicine’s focus on addressing glucose homeostasis dysregulation and controlling the progression of Type 2 diabetes and the occurrence of its complications from the source.Dorzagliatin was approved for marketing by the China National Medical Products Administration (NMPA) in September 2022 for two indications, both to improve blood glucose control for T2D patients:1) It can be used as mono-therapy treatment for drug-naïve T2D patients, as first-line treatment,2) When metformin hydrochloride alone exhibits poor blood glucose control in T2D patients, it can be used in combination with metformin hydrochloride.Since January 1, 2024, dorzagliatin is included in China’s National Reimbursement Drug List and has been prescribed to over 200,000+ patients in mainland China already. In June last year, the interim analysis of real-world research presented at the Scientific Sessions of the American Diabetes Association (ADA) further verified its efficacy and safety in a broad population.Leveraging Hong Kong's "1+" Mechanism to Accelerate Access to Innovative Drugs for Hong Kong ResidentsThe formulation and implementation of Hong Kong's "1+" pharmaceutical regulatory innovation mechanism is an important measure taken by the Hong Kong SAR Government to enhance the accessibility of medical innovation and attract high-quality global innovative drugs to launch in Hong Kong. This mechanism allows innovative drugs already approved in designated major markets (such as China, the United States, Europe, etc.) to secure marketing approval in Hong Kong through a simplified application pathway and data mutual recognition mechanism, which greatly shortens the time cycle from R&D to clinical access of innovative drugs for Hong Kong patients, while ensuring the safety and efficacy of the drugs.With its local clinical data, clear therapeutic value and good safety record in China, dorzagliatin has become one of the first original Chinese innovative drugs to be rapidly approved through Hong Kong's "1+" mechanism. This approval is an important practical achievement of the mechanism in enabling the launch of global innovative drugs in Hong Kong, which not only reflects the high recognition of the clinical value of dorzagliatin by the Department of Health of Hong Kong, but also highlights the core role of the "1+" mechanism in connecting the Chinese market and international pharmaceutical markets and accelerating the flow of innovative medical resources.Building on Hong Kong's Experience to Empower Global Diabetes ManagementDiabetes is a major challenge for global public health.  According to the 2025 Global Diabetes Map released by the International Diabetes Federation (IDF), the number of adults aged 20-79 with diabetes worldwide reached 589 million in 2024, and this figure is projected to rise to 853 million by 2050.  In Hong Kong, China, diabetes is also a prominent public health issue. According to the Population Health Survey 2020-2022 conducted by the Department of Health of Hong Kong, 6.9% of people aged 15 or above reported having been diagnosed with diabetes by a doctor, and an additional 1.8% had hyperglycemia without being diagnosed with diabetes. In 2022, more than 600 death registrations in Hong Kong were attributed to diabetes, ranking 11th among the leading causes of death.[1]Hong Kong has accumulated rich experience in diabetes management, forming a comprehensive system covering disease surveillance, prevention, screening, treatment and community management, and its community-based public-private partnership model for diabetes management has achieved remarkable results. Following its launch in Hong Kong, dorzagliatin is expected to be deeply integrated with the local mature diabetes management system, and help improve patients' quality of life, control disease progression and reduce medical burdens through personalized treatment plans.At present, Hua Medicine is collaborating with the research team led by Professor Juliana Chan, a world-renowned endocrinologist from the Chinese University of Hong Kong, to conduct the SENSITIZE series of studies to further explore the mechanism by which dorzagliatin improves pancreatic β-cell glucose sensitivity. The published results of the SENSITIZE 1/2 studies have shown that dorzagliatin can significantly improve the second-phase insulin secretion and β-cell glucose sensitivity in patients with glucokinase monogenic diabetes (GCK-MODY or MODY-2), and enhance basal insulin secretion in patients with newly diagnosed type 2 diabetes. In addition, dorzagliatin can also significantly improve the second-phase insulin secretion and β-cell glucose sensitivity in populations with impaired glucose tolerance (IGT).Hua Medicine will continue to deepen cooperation with top local research institutions and clinicians to further explore the potential of dorzagliatin in pre-diabetes intervention, early treatment and complication prevention, accumulate additional international clinical data, lay a solid foundation for the expansion of its indications and global market promotion, and establish personalized intervention and treatment management plans for patients with pre-diabetes and Type 2 diabetes.As a core hub of the Asian pharmaceutical market, Hong Kong, with its unique geographical location, advanced medical infrastructure, international business environment and close linkage with the Southeast Asian market, is expected to become the strategic starting point for Hua Medicine to expand into Southeast Asia and the global market. Relying on Hong Kong's advantage of pharmaceutical regulatory standards aligned with international norms and leveraging its financial and capital market strengths, Hua Medicine will further advance the registration and application of dorzagliatin in the Southeast Asian market to quickly cover the large population of diabetes patients in the region. Meanwhile, the Company will deepen cooperation with partners in the global pharmaceutical industry chain to accelerate the international commercialization of dorzagliatin.Forward-Looking StatementsThis document contains statements regarding Hua Medicine's and its products' future expectations, plans and prospects. Such forward-looking statements relate only to events or information as of the date on which the statements are made in this document and are subject to change in light of future developments. Except as required by law, the Company shall not be obligated to update or publicly revise any forward-looking statements or unforeseen events after the date of such statements, whether as a result of new information, future events or other circumstances. Please read this document carefully and understand that actual future performance or results of the Company may differ materially from expectations due to various risks, uncertainties or other statutory requirements.About Hua MedicineHua Medicine (The “Company”) is an innovative drug development and commercialization company based in Shanghai, China, with companies in the United States and Hong Kong. Hua Medicine focuses on developing novel therapies for patients with unmet medical needs worldwide. Based on global resources, Hua Medicine teams up with global high-calibre people to develop breakthrough technologies and products, which contribute to innovation in diabetes care. Hua Medicine's cornerstone product HuaTangNing (dorzagliatin tablets), targets the glucose sensor glucokinase, restores glucose sensitivity in T2D patients, and stabilizes imbalances in blood glucose levels in patients. HuaTangNing was approved by the National Medical Products Administration (NMPA) of China on September 30th, 2022. It can be used alone or in combination with metformin for adult T2D patients. For patients with chronic kidney disease (CKD), no dose adjustment is required. It is an oral hypoglycemic drug that can be used for patients with Type 2 diabetes with renal function impairment. In February 2026, dorzagliatin (Trade name: MYHOMSIS(R)) was approved for marketing by the Pharmaceutical Services of the Department of Health of the Government of the Hong Kong Special Administrative Region of China.For more informationHua MedicineWebsite: www.huamedicine.comInvestorsEmail: ir@huamedicine.comMediaEmail:pr@huamedicine.com[1] https://www.chp.gov.hk/sc/features/37474.html Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

3 3 月, 2026

Affiliate of Pacific Avenue Capital Partners to Acquire Care.com from IAC

LOS ANGELES, CA, Mar 3, 2026 - (ACN Newswire via SeaPRwire.com) - Pacific Avenue Capital Partners ("Pacific Avenue"), a Los Angeles-headquartered private equity firm focused on corporate carve-outs and other complex transactions in the middle market, today announced that an affiliate of Pacific Avenue has entered into an agreement to acquire Care.com from IAC Inc. (NASDAQ:IAC).Care.com is a leading platform and brand in the growing $400 billion market for family care, anchored by the largest online network of background-checked child and senior caregivers in the U.S.Care.com operates both a scaled consumer marketplace and an enterprise benefits platform. Since 2007, more than 45 million people have turned to Care.com to find child care, senior care, pet care and housekeeping support. Care.com also partners with more than 700 employers, including many of the Fortune 100, to deliver care-related benefits that combine access to the Care.com platform and comprehensive backup care solutions provided in-home, in-center and through camps and activities, along with a broader suite of care support solutions.As a standalone company, Care.com will accelerate its enterprise expansion while continuing to strengthen its consumer marketplace. With Pacific Avenue's investment and support, the Company will move faster on product innovation, scale its employer partnerships, and enhance the platform experience for the millions of families and caregivers who rely on it."We are thrilled to announce the Care.com transaction, the first investment in Pacific Avenue Fund II. The transaction aligns perfectly with Pacific Avenue's track record of executing corporate carve-outs to acquire market-leading businesses. Care.com is an industry leader with a brand built on trust, a strong reputation, and a proven leadership team. Care.com has a clear path for growth as an independent, standalone company. We're excited to work with Brad, Michelle, and the Care.com team to unlock the company's full potential in serving families, caregivers, and its enterprise partners."- Chris Sznewajs, Founder and Managing Partner of Pacific Avenue"Caregiving is foundational to how families live and how businesses operate," said Brad Wilson, CEO of Care.com. "This partnership allows us to deepen our support for families and caregivers while expanding the ways we serve employers who recognize that caregiving is a workforce issue. We're entering this next chapter with strength, clarity, and a renewed commitment to building the most beloved platform for care.""Care.com enters this next chapter with a profitable foundation. This transaction positions us to further invest in our platform, expand our employer partnerships, and scale efficiently while maintaining the financial discipline that has strengthened our performance," said Michelle Arbov, Chief Financial Officer of Care.com.The transaction is subject to customary closing conditions and is expected to be completed in the first half of 2026.Moelis & Company LLC served as exclusive financial advisor to Pacific Avenue. Weil, Gotshal & Manges LLP served as legal advisor to Pacific Avenue.KPMG LLP provided accounting and tax advisory services. J.P. Morgan Securities LLC acted as exclusive financial advisor to IAC and Latham and Watkins LLP served as legal counsel to IAC.About Pacific Avenue Capital PartnersPacific Avenue Capital Partners is a global private equity firm headquartered in Los Angeles with an office in Paris. The firm is focused on corporate divestitures and other complex situations in the middle market. Pacific Avenue has extensive M&A and operations experience, allowing the firm to navigate complex transactions and unlock value through operational improvement, capital investment, and accelerated growth. Pacific Avenue takes a collaborative approach in partnering with strong management teams to drive lasting and strategic change while assisting businesses in reaching their full potential. Pacific Avenue has approximately $3.8 billion of Assets Under Management (AUM) as of September 30, 2025. For more information, please visit www.pacificavenuecapital.com.Contact InformationChris BaddonManaging Directorcbaddon@pacificavenuecapital.comSOURCE: Pacific Avenue Capital Partners Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

3 3 月, 2026